Insider Purchase: Cai Suixiong Boosts Stake in Impact Therapeutics with HK$1.46 Million Deal

Stock News09-03 19:34

Data from the Hong Kong Stock Exchange reveals that on September 1, Cai Suixiong increased his holding in IMPACT THERAP-B (07630) by 100,000 shares at a price of HK$14.6105 per share, totaling HK$1.461 million.

Following this transaction, his latest shareholding stands at approximately 18.5409 million shares, representing a 6.56% stake in the company. Additional information indicates that the capacity in which shares are held in box 24 are set out in box 27.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment